TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›HHS›Financials
Annual statements · SEC XBRL · FY2016 – FY2025

HARTE HANKS INC (HHS) financials

Income statement

HARTE HANKS INC (HHS) income statement, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$404M$384M$285M$218M$177M$195M$206M$191M$185M$160M
Revenue growth—-5.1%-25.9%-23.6%-18.7%10.0%6.0%-7.2%-3.3%-13.9%
Operating income-$53.8M-$40.9M-$26.0M-$21.6M-$10.6M$7.64M$15.1M$3.36M$2.09M$386K
Operating margin-13.3%-10.6%-9.1%-9.9%-6.0%3.9%7.3%1.8%1.1%0.2%
Net income—-$41.9M$17.6M-$26.3M-$1.69M$15.0M$36.8M-$1.57M-$30.3M-$811K
Net margin—-10.9%6.2%-12.1%-1.0%7.7%17.8%-0.8%-16.4%-0.5%
EPS (diluted)-$21.29-$6.76$2.38-$4.26-$0.34$1.76$4.75-$0.21-$4.15-$0.11

Cash flow

HARTE HANKS INC (HHS) cash flow, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$14.6M-$30.8M-$9.18M$12.1M-$7.84M-$1.76M$28.8M$10.5M-$2.99M-$1.74M
Capital expenditures$6.69M$5.68M$4.21M$2.90M$2.70M$3.05M$5.80M$2.81M$3.75M$2.76M
Free cash flow$7.90M-$36.5M-$13.4M$9.20M-$10.5M-$4.81M$23.0M$7.67M-$6.73M-$4.49M
Share buybacks$0.00$0.00————$0.00$2.37M$0.00—
Dividends paid$5.29M$0.00————————

Balance sheet

HARTE HANKS INC (HHS) balance sheet, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$46.0M$8.40M$20.9M$28.1M$29.4M$11.9M$10.4M$18.4M$9.81M$5.58M
Total assets$213M$131M$125M$110M$119M$108M$120M$123M$102M$91.8M
Total liabilities$211M$165M$135M$150M$163M$123M$101M$103M$80.1M$71.3M
Long-term debt$0.00$0.00$14.2M$18.7M$22.2M$5.00M$0.00———
Shareholders' equity$2.66M-$34.6M-$19.2M-$49.7M-$53.1M-$24.7M$18.8M$19.9M$21.7M$20.5M
Retained earnings$837M$795M$813M$798M$796M$811M$846M$845M$815M$814M
Shares (wtd avg diluted)6.15M6.19M6.27M6.28M6.47M7.21M7.46M7.31M7.29M7.39M

Every figure is extracted from HARTE HANKS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is HARTE HANKS INC's annual revenue?
HARTE HANKS INC (HHS) reported $160M of revenue for fiscal year 2025 — down 13.9% from $185M in FY2024, per its annual report filed with the SEC.
Is HARTE HANKS INC profitable?
Not in FY2025 — HHS reported a net loss of $811K, per SEC filings.
What is HARTE HANKS INC's free cash flow?
-$4.49M in FY2025 (operating cash flow -$1.74M minus $2.76M of capital expenditures), from the SEC cash-flow statement.
Does HHS pay a dividend?
HARTE HANKS INC reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full HHS analysis — verdict, score & filings →Is HHS a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.